KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Gross Margin: 2009-2024

Historic Gross Margin for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to 48.74%.

  • Teva Pharmaceutical Industries' Gross Margin rose 184.00% to 51.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 50.10%, marking a year-over-year increase of 26.00%. This contributed to the annual value of 48.74% for FY2024, which is 50.00% up from last year.
  • According to the latest figures from FY2024, Teva Pharmaceutical Industries' Gross Margin is 48.74%, which was up 1.03% from 48.25% recorded in FY2023.
  • Over the past 5 years, Teva Pharmaceutical Industries' Gross Margin peaked at 48.74% during FY2024, and registered a low of 46.38% during FY2020.
  • Its 3-year average for Gross Margin is 47.90%, with a median of 48.25% in 2023.
  • As far as peak fluctuations go, Teva Pharmaceutical Industries' Gross Margin spiked by 175bps in 2020, and later crashed by 111bps in 2022.
  • Over the past 5 years, Teva Pharmaceutical Industries' Gross Margin (Yearly) stood at 46.38% in 2020, then surged by 145bps to 47.83% in 2021, then tumbled by 111bps to 46.72% in 2022, then surged by 153bps to 48.25% in 2023, then surged by 50bps to 48.74% in 2024.